ID   CAT(Wil)
AC   CVCL_W772
SY   CAT; Wil
DR   Wikidata; Q54808621
RX   PubMed=1828972;
RX   PubMed=8512807;
RX   PubMed=10948322;
RX   PubMed=12127398;
RX   PubMed=29732388;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
RX   PubMed=1828972; DOI=10.1016/0277-5379(91)90241-5;
RA   Nouri A.M.E., Bergbaum A., Lederer E., Crosby D., Shamsa A.,
RA   Oliver R.T.D.;
RT   "Paired tumour infiltrating lymphocyte (TIL) and tumour cell line from
RT   bladder cancer: a new approach to study tumour immunology in vitro.";
RL   Eur. J. Cancer 27:608-612(1991).
//
RX   PubMed=8512807; DOI=10.1038/bjc.1993.229;
RA   Nouri A.M.E., Hussain R.F., Dos Santos A.V.L., Mansouri M.,
RA   Oliver R.T.D.;
RT   "Intensity of class I antigen expression on human tumour cell lines
RT   and its relevance to the efficiency of non-MHC-restricted killing.";
RL   Br. J. Cancer 67:1223-1228(1993).
//
RX   PubMed=10948322; DOI=10.3892/or.7.5.959;
RA   Nouri A.M.E., Symes M.O.;
RT   "Comparative assessment of MHC antigen expression in bladder and
RT   testis tumour biopsies and established urological tumour cell lines:
RT   the relevance of cytokine and gene transfection for correction of
RT   defective MHC antigens.";
RL   Oncol. Rep. 7:959-964(2000).
//
RX   PubMed=12127398; DOI=10.1016/S0165-4608(01)00648-3;
RA   Strefford J.C., Lillington D.M., Steggall M., Lane T.M., Nouri A.M.E.,
RA   Young B.D., Oliver R.T.D.;
RT   "Novel chromosome findings in bladder cancer cell lines detected with
RT   multiplex fluorescence in situ hybridization.";
RL   Cancer Genet. Cytogenet. 135:139-146(2002).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//